As leader of the Laforest Lab, he is focused on quantitative nuclear medicine and PET methods using multimodality SPECT/CT, PET/CT and PET/MRI for the study of various diseases related to inflammation, oncology and cardiology.
Laforest is a member of several professional organizations including the Society of Nuclear Medicine and the American Associate of Physicists in Medicine. In 2023, he was honored with the Distinguished Investigator Award by the Academy for Radiology and Biomedical Imaging Research in celebration of his high level of achievement in the field of imaging research. He has published more than 90 peer-reviewed papers as well as several book chapters and review articles.